Hepatitis, Viral, Human
26
0
0
22
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.7%
2 terminated out of 26 trials
91.7%
+5.2% vs benchmark
19%
5 trials in Phase 3/4
14%
3 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (26)
Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis
Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination
Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines
Genes Involved in Resistance or Susceptibility to Hepatitis B Virus
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
Delta Hepatitis and Liver Disease in Hemophiliacs
Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin
Prospective Study of HIV Infection in Hemophiliacs
Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002)
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Hepatitis C in Clinically Discordant Hemophilic Siblings
Hepatitis Delta Infections in Hemophiliacs
Retrovirus Epidemiology Donor Study-II (REDS-II)
Natural History of Post-transfusion Non-A, Non-B Hepatitis
Risk of Post Transfusion Hepatitis C Virus Infection
Transfusion Infections Pediatric Prospective Study (TRIPPS)
Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom)
Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin
Hepatitis B Vaccine Clinical Trial